Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 24 Mar 2017 |
10 | Certificate | 01 Aug 2019 |
2 | Power of Attorney | 24 Mar 2017 |
3 | Reply to Exam Report (MIS-R) | 21 Jul 2017 |
4 | Reply to Exam Report (MIS-R) | 24 Jul 2017 |
5 | Reply to Exam Report (MIS-R) | 26 Jul 2017 |
6 | Incorpration Certificate | 18 Jul 2018 |
7 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 28 Feb 2019 |
8 | Authorization Letter | 11 Mar 2019 |
9 | Journal Copy | 30 May 2019 |
1 | Dispatching of Examination Report for : 3513918 | 4841434 | 2091546 | 16 Jun 2017 |
2 | Hearing Notice (Show Cause) | 7588625 | 3689056 | 08 Jan 2019 |
3 | Tribunal Accepted Notice for : 3513918 | 7931439 | 3874037 | 11 Mar 2019 |
The application for Virtaf hep-b was made on 24 March 2017.
The trademark applicant for Virtaf hep-b is STRIDES PHARMA SCIENCE.
Virtaf hep-b is applied in class(es) 5.
Application for Virtaf hep-b is on Registered stage.
Application Id allotted to Virtaf hep-b is 3513918.
Trademark agent or attorney for the application is Altacit Global.
Virtaf hep-b filed with the Intellectual property office as a WORD.